Sujit Biswas

An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants

Manu Sebastian, A. Saeedi, Mohsen Fathi, 2022, bioRxiv.

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

Vineet D. Menachery, B. Keyt, Xuping Xie, 2021, Nature.

FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.

B. Hann, A. Bigley, N. Agha, 2021, Blood advances.

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2

C. Yee, Mohsen Fathi, N. Varadarajan, 2020, bioRxiv.

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2

C. Yee, Mohsen Fathi, N. Varadarajan, 2021, iScience.

Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils.

V. Tam, K. Rumbaugh, Xinli Liu, 2022, Biomaterials science.

An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models

A. Saeedi, Mohsen Fathi, N. Varadarajan, 2024, Nature communications.